The American Journal of Surgical Pathology · 2020 · 36 citations · 23 references
MedicineEndocrinologyPathologyAndrologyReproductive EndocrinologyReproductive PathologyBenign Prostatic HyperplasiaDisorders Of Sex DevelopmentGender DysphoriaProstate PathologyProstatic PathologyReproductive Tract NeoplasiaAndrogen Excess DisordersAndrogen Excess TreatmentGlandular MetaplasiaHistopathology Of Prostatic HyperplasiaOvotesticular Developmental DisordersProstatic AnatomyProstatic MetaplasiaTestosterone Therapy
Prostatic-type differentiation in the lower female genital tract is encountered rarely and its causes and clinical associations are not well established. Within the vagina, reports to date have invariably described ectopic prostatic-type differentiation as restricted to the lamina propria. We recently encountered a patient receiving testosterone for gender dysphoria whose vaginectomy specimen showed a prostatic glandular proliferation within the surface epithelium. To elucidate its potential association with androgen exposure, we sought similar lesions, resected over a 26-year period, from patients with exogenous or endogenous androgen excess. Thirteen cases were identified, involving the vagina (n=12) and exocervix (n=1). The most common clinical context was gender dysphoria with long-term testosterone therapy; the lesion was present in 7 of 8 gender-dysphoric patients examined. Four other patients had congenital disorders of sexual development associated with endogenous androgen excess (congenital adrenal hyperplasia, 46,XY disorder of sexual development, and ovotesticular disorder of sexual development). Two had no known exposure to androgen excess. Immunohistochemically, glands stained for NKX3.1 (100% of cases), androgen receptor (100%), CK7 (92%), and prostate-specific antigen (69%). Follow-up (median duration, 11 mo) showed no masses or neoplasia. We propose the designation "androgen-associated prostatic metaplasia" for this form of prostate tissue with distinctive clinical, histologic and immunohistochemical features. It is novel and previously unrecognized within the vagina. It is strikingly prevalent among patients undergoing gender-affirming surgery, an increasingly common procedure. Recognition is important to distinguish it from other potentially neoplastic glandular lesions and facilitate accrual of more follow-up data to better understand its natural history.
23
Temporal Trends in Gender-Affirming Surgery Among Transgender Patients in the United States
Joseph K. Canner, Omar Harfouch, Lisa M. Kodadek et al. · JAMA Surgery · 2018 · 364 citations · Full text
New insights into human female reproductive tract development
Stanley J. Robboy, Takeshi Kurita, Laurence S. Baskin et al. · Differentiation · 2017 · 112 citations · Full text
Histological changes in the genital tract in transsexual women following androgen therapy
Nicola Miller, Yvan C. Bédard, N. Cooter et al. · Histopathology · 1986 · 108 citations
Medicine, Endocrinology, Gynecology +14